| 1 | Medulloblastoma | 45.2% |
| 2 | Ganglioneuroma | 39.4% |
| 3 | Glioma | 39.4% |
| 4 | Malignant Glioma | 39.4% |
| 5 | Astrocytoma | 29.5% |
| 6 | Ependymoma | 29.5% |
| 7 | oligodendroglioma | 29.5% |
| 8 | Ganglioglioma | 29.5% |
| 9 | gliosarcoma | 29.5% |
| 10 | Anaplastic astrocytoma | 29.5% |
| 11 | Anaplastic Oligodendroglioma | 29.5% |
| 12 | Uveal Neoplasms | 27.1% |
| 13 | Craniopharyngioma | 25.5% |
| 14 | Neuroectodermal Tumor, Melanotic | 25.5% |
| 15 | Neuroendocrine Tumors | 25.5% |
| 16 | Retinal Degeneration | 25.3% |
| 17 | Retinal Dysplasia | 24.6% |
| 18 | Glioblastoma | 24.6% |
| 19 | Neuroblastoma | 24.6% |
| 20 | Glioblastoma Multiforme | 24.6% |
| 21 | melanoma | 24.5% |
| 22 | Adenoma, Acidophil | 23.8% |
| 23 | Optic Nerve Glioma | 22.7% |
| 24 | Ganglioneuroblastoma | 22.2% |
| 25 | Carcinoid Tumor | 21.5% |
| 26 | Meningioma | 21.5% |
| 27 | Eyelid Neoplasms | 21% |
| 28 | Neurilemmoma | 20.8% |
| 29 | Melanoma, Experimental | 19.9% |
| 30 | leukemia | 19.5% |
| 31 | Aniridia | 19.5% |
| 32 | Trophoblastic Neoplasms | 18.6% |
| 33 | Basal cell carcinoma | 18.2% |
| 34 | Carcinoma, Papillary | 18.2% |
| 35 | Squamous cell carcinoma | 18.2% |
| 36 | Cystadenoma | 18.2% |
| 37 | Mesothelioma | 18.2% |
| 38 | Carcinoma, Basal Cell | 18.2% |
| 39 | Carcinoma, Lobular | 17.8% |
| 40 | Hutchinson's Melanotic Freckle | 17.6% |
| 41 | Melanoma, Amelanotic | 17.6% |
| 42 | Retinitis Pigmentosa | 17.5% |
| 43 | Pigmentary retinopathy | 17.5% |
| 44 | Paraganglioma | 17.4% |
| 45 | Histiocytic Disorders, Malignant | 17.3% |
| 46 | Retinal Hemorrhage | 17.3% |
| 47 | Duane Retraction Syndrome | 17% |
| 48 | Malignant Carcinoid Syndrome | 16.7% |
| 49 | Carcinoma, Ehrlich Tumor | 16.2% |
| 50 | Carcinoma, Lewis Lung | 16.2% |
| 51 | Composite Lymphoma | 16.1% |
| 52 | Carcinosarcoma | 16.1% |
| 53 | Hemangiosarcoma | 16.1% |
| 54 | lymphangiosarcoma | 16.1% |
| 55 | Adenoma | 16% |
| 56 | Carcinoma | 16% |
| 57 | Epithelioma | 16% |
| 58 | Carcinoma 256, Walker | 15.8% |
| 59 | Lymphoma | 15.6% |
| 60 | Cystadenocarcinoma | 15.6% |
| 61 | Mucoepidermoid Carcinoma | 15.6% |
| 62 | Retinoblastoma | 15.5% |
| 63 | Choriocarcinoma | 15.5% |
| 64 | Dermoid Cyst | 15.4% |
| 65 | Multiple Endocrine Neoplasia | 15.4% |
| 66 | Acanthoma | 15.3% |
| 67 | Leukemia, Experimental | 15.2% |
| 68 | Chordoma | 15.2% |
| 69 | Teratoma | 15.2% |
| 70 | Germinoma | 15.2% |
| 71 | Teratocarcinoma | 15.2% |
| 72 | Hamartoma | 14.8% |
| 73 | Neoplasms, Hormone-Dependent | 14.8% |
| 74 | Neoplasms, Multiple Primary | 14.8% |
| 75 | Paraneoplastic Syndromes | 14.8% |
| 76 | Precancerous Conditions | 14.8% |
| 77 | Neoplasms, Second Primary | 14.8% |
| 78 | Leukemia, Plasma Cell | 14.4% |
| 79 | Neuroectodermal Tumors | 14.3% |
| 80 | Neoplasms, Neuroepithelial | 14.1% |
| 81 | Gliomatosis cerebri | 14.1% |
| 82 | Acoustic Neuroma | 14% |
| 83 | Leukemia, Radiation-Induced | 13.9% |
| 84 | Neoplasms, Germ Cell and Embryonal | 13.9% |
| 85 | Germ Cell Cancer | 13.9% |
| 86 | Color blindness | 13.8% |
| 87 | Chorioretinitis | 13.7% |
| 88 | Eye Neoplasms | 13.6% |
| 89 | Asthenopia | 13.5% |
| 90 | Conjunctival Diseases | 13.5% |
| 91 | Corneal Diseases | 13.5% |
| 92 | Eyelid Diseases | 13.5% |
| 93 | Lacrimal Apparatus Diseases | 13.5% |
| 94 | Lens Diseases | 13.5% |
| 95 | Ocular Hypertension | 13.5% |
| 96 | Ocular Hypotension | 13.5% |
| 97 | Scleral Diseases | 13.5% |
| 98 | Vitreous Detachment | 13.5% |
| 99 | Posterior Vitreous Detachment | 13.5% |
| 100 | Pheochromocytoma | 13.4% |
| 101 | Blepharophimosis | 13.4% |
| 102 | Angioid Streaks | 13.3% |
| 103 | Neoplasms, Glandular and Epithelial | 13.3% |
| 104 | Retinal Detachment | 13.3% |
| 105 | Retinitis | 13.3% |
| 106 | Cyst | 13.2% |
| 107 | Neoplastic Processes | 13.2% |
| 108 | Neoplastic Syndromes, Hereditary | 13.2% |
| 109 | Pregnancy Complications, Neoplastic | 13.2% |
| 110 | Carcinoid Heart Disease | 13.1% |
| 111 | Neoplasms, Experimental | 13.1% |
| 112 | Bowen's Disease | 13% |
| 113 | Carcinoma, Pancreatic Ductal | 12.7% |
| 114 | Xerophthalmia | 12.5% |
| 115 | Low Tension Glaucoma | 12.5% |
| 116 | Iridocorneal endothelial syndrome | 12.5% |
| 117 | Adenofibroma | 12.5% |
| 118 | Fibroadenoma | 12.5% |
| 119 | Thymoma | 12.5% |
| 120 | Chondrosarcoma | 12.4% |
| 121 | leiomyosarcoma | 12.4% |
| 122 | liposarcoma | 12.4% |
| 123 | synovial sarcoma | 12.4% |
| 124 | Angiomyolipoma | 12.4% |
| 125 | Clear Cell Sarcoma of Soft Tissue | 12.4% |
| 126 | Alveolar Soft Part Sarcoma | 12.4% |
| 127 | Sarcoma, Myeloid | 12.4% |
| 128 | Basal Cell Nevus Syndrome | 12.3% |
| 129 | Eye Abnormalities | 12.1% |
| 130 | Eye Infection | 12.1% |
| 131 | Eye Manifestations | 12.1% |
| 132 | Optic Neuropathy | 12.1% |
| 133 | Corneal Scar | 12% |
| 134 | Paraneoplastic Encephalomyelitis | 12% |
| 135 | Abdominal Neoplasms | 12% |
| 136 | Head and Neck Neoplasms | 12% |
| 137 | Soft Tissue Neoplasms | 12% |
| 138 | Thoracic Neoplasms | 12% |
| 139 | Tuberous Sclerosis | 11.9% |
| 140 | Mammary Neoplasms, Experimental | 11.9% |
| 141 | Sarcoma, Experimental | 11.9% |
| 142 | Neoplasms, Radiation-Induced | 11.8% |
| 143 | Retinal Artery Occlusion | 11.8% |
| 144 | Retinopathy of Prematurity | 11.8% |
| 145 | Retinal Vasculitis | 11.8% |
| 146 | Hypertensive Retinopathy | 11.8% |
| 147 | Keratoconjunctivitis Sicca | 11.8% |
| 148 | Nephroblastoma | 11.8% |
| 149 | Retinal Neovascularization | 11.8% |
| 150 | Endometrial Stromal Sarcoma | 11.5% |
| 151 | Vipoma | 11.3% |
| 152 | Corneal Ulcer | 11.3% |
| 153 | Choroid Hemorrhage | 11.3% |
| 154 | Ameloblastoma | 11.1% |
| 155 | Angiokeratoma | 11.1% |
| 156 | Hemangioma | 11.1% |
| 157 | hemangiopericytoma | 11.1% |
| 158 | Lymphangioma | 11.1% |
| 159 | Mesenchymoma | 11.1% |
| 160 | Nevus | 11.1% |
| 161 | Hepatoblastoma | 11.1% |
| 162 | Mixed Tumor, Mullerian | 11.1% |
| 163 | Angiofibroma | 11.1% |
| 164 | Sarcoma | 11.1% |
| 165 | Digestive System Neoplasms | 10.9% |
| 166 | Endocrine Gland Neoplasms | 10.9% |
| 167 | Nervous System Neoplasms | 10.9% |
| 168 | Ocular Motility Disorders | 10.9% |
| 169 | Cyclophoria | 10.9% |
| 170 | Pupil Disorders | 10.8% |
| 171 | Cytomegalovirus Retinitis | 10.8% |
| 172 | Bone neoplasms | 10.8% |
| 173 | Skin Neoplasms | 10.8% |
| 174 | Hematologic Neoplasms | 10.8% |
| 175 | Eye Hemorrhage | 10.8% |
| 176 | Hepatocellular Adenoma | 10.7% |
| 177 | Vision Disorders | 10.7% |
| 178 | Metamorphopsia | 10.7% |
| 179 | Visual Impairment | 10.7% |
| 180 | Eye Injuries | 10.7% |
| 181 | Splenic Neoplasms | 10.7% |
| 182 | Retinal Vein Occlusion | 10.6% |
| 183 | Diabetic Retinopathy | 10.6% |
| 184 | Trachoma | 10.6% |
| 185 | Fibrosarcoma | 10.5% |
| 186 | Osteosarcoma | 10.5% |
| 187 | Parathyroid Neoplasms | 10.3% |
| 188 | Peritoneal Neoplasms | 10.3% |
| 189 | Thyroid Neoplasm | 10.3% |
| 190 | Thyroid carcinoma | 10.3% |
| 191 | Keratoconjunctivitis | 10.3% |
| 192 | Adenocarcinoma | 10.2% |
| 193 | Carcinoma in Situ | 10.2% |
| 194 | Carcinoma, Transitional Cell | 10.2% |
| 195 | Papilloma | 10.2% |
| 196 | Pseudomyxoma Peritonei | 10.2% |
| 197 | Papillomatosis | 10.2% |
| 198 | Adenomatosis, Pulmonary | 10.2% |
| 199 | Adenomatous Polyps | 10.2% |
| 200 | Carcinoma, Large Cell | 10.2% |
| 201 | Carcinoma, Small Cell | 10.2% |
| 202 | Hordeolum | 10.2% |
| 203 | Leukemia L1210 | 10.2% |
| 204 | Leukemia P388 | 10.2% |
| 205 | Neurofibrosarcoma | 10.1% |
| 206 | Lymphangioleiomyomatosis | 10.1% |
| 207 | Pars Planitis | 10% |
| 208 | Opsoclonus-Myoclonus Syndrome | 9.9% |
| 209 | Plasmacytoma | 9.9% |
| 210 | Malignant histiocytosis | 9.9% |
| 211 | Histiocytic sarcoma | 9.9% |
| 212 | Prolactinoma | 9.8% |
| 213 | Growth Hormone-Secreting Pituitary Adenoma | 9.8% |
| 214 | Malignant Fibrous Histiocytoma | 9.6% |
| 215 | Pancreatic Neoplasm | 9.5% |
| 216 | Dysgerminoma | 9.4% |
| 217 | Neuroma | 9.4% |
| 218 | Seminoma | 9.4% |
| 219 | Retinal Diseases | 9.3% |
| 220 | Aicardi's syndrome | 9.2% |
| 221 | Lymphomatoid Granulomatosis | 9.2% |
| 222 | Macular degeneration | 9.1% |
| 223 | Retinal Drusen | 9.1% |
| 224 | Retinal Necrosis Syndrome, Acute | 9.1% |
| 225 | Retinoschisis | 9.1% |
| 226 | Multiple Endocrine Neoplasia Type 1 | 9% |
| 227 | Carcinoma, Ovarian Epithelial | 9% |
| 228 | Adenomatous Polyposis Coli | 8.9% |
| 229 | Hodgkin Disease | 8.9% |
| 230 | Lymphoma, Non-Hodgkin | 8.9% |
| 231 | Mesoblastic Nephroma | 8.8% |
| 232 | Rhabdomyosarcoma | 8.7% |
| 233 | Giant Cell Tumor of Bone | 8.7% |
| 234 | CHARGE Syndrome | 8.6% |
| 235 | Optic Atrophy, Hereditary, Leber | 8.6% |
| 236 | Choroiditis | 8.6% |
| 237 | Iridocyclitis | 8.6% |
| 238 | Iritis | 8.6% |
| 239 | Albinism | 8.5% |
| 240 | insulinoma | 8.5% |
| 241 | Tracheal Neoplasms | 8.5% |
| 242 | Acanthamoeba Keratitis | 8.5% |
| 243 | Keratitis, Herpetic | 8.4% |
| 244 | Bacterial conjunctivitis | 8.4% |
| 245 | Sarcoma 180 | 8.4% |
| 246 | Corneal Perforation | 8.3% |
| 247 | Anisometropia | 8.3% |
| 248 | Aphakia | 8.3% |
| 249 | Astigmatism | 8.3% |
| 250 | Blepharitis | 8.3% |
| 251 | Blepharoptosis | 8.3% |
| 252 | Blepharospasm | 8.3% |
| 253 | Choroid Diseases | 8.3% |
| 254 | Conjunctivitis | 8.3% |
| 255 | Corneal edema | 8.3% |
| 256 | Corneal Opacity | 8.3% |
| 257 | Dacryocystitis | 8.3% |
| 258 | Dry Eye Syndromes | 8.3% |
| 259 | Ectropion | 8.3% |
| 260 | Enophthalmos | 8.3% |
| 261 | Entropion | 8.3% |
| 262 | Episcleritis | 8.3% |
| 263 | Exophthalmos | 8.3% |
| 264 | Glaucoma | 8.3% |
| 265 | Iris Diseases | 8.3% |
| 266 | Keratitis | 8.3% |
| 267 | Keratoconus | 8.3% |
| 268 | Lacrimal Duct Obstruction | 8.3% |
| 269 | Lens dislocation | 8.3% |
| 270 | Lens Subluxation | 8.3% |
| 271 | Mydriasis | 8.3% |
| 272 | Myopia | 8.3% |
| 273 | Presbyopia | 8.3% |
| 274 | Pterygium | 8.3% |
| 275 | Scleritis | 8.3% |
| 276 | Uveitis | 8.3% |
| 277 | Corneal Neovascularization | 8.3% |
| 278 | Orbital Pseudotumor | 8.3% |
| 279 | Cataract | 8.3% |
| 280 | Pinguecula | 8.3% |
| 281 | Trichiasis | 8.3% |
| 282 | Liver Neoplasms, Experimental | 8.3% |
| 283 | Primary amyloidosis | 8.1% |
| 284 | Erythroplasia | 7.9% |
| 285 | Follicular cyst | 7.9% |
| 286 | Mucocele | 7.9% |
| 287 | Pilonidal Cyst | 7.9% |
| 288 | Thyroglossal Cyst | 7.9% |
| 289 | Synovial Cyst | 7.9% |
| 290 | Aberrant Crypt Foci | 7.9% |
| 291 | Dermatofibrosarcoma | 7.8% |
| 292 | Dermatofibrosarcoma Protuberans | 7.8% |
| 293 | Mandibulofacial Dysostosis | 7.7% |
| 294 | Esophageal Neoplasms | 7.7% |
| 295 | Panophthalmitis | 7.7% |
| 296 | Gastrinoma | 7.6% |
| 297 | Glucagonoma | 7.6% |
| 298 | neurofibroma | 7.5% |
| 299 | Hydatidiform Mole | 7.5% |
| 300 | Anophthalmos | 7.4% |
| 301 | Endophthalmitis | 7.4% |
| 302 | Microphthalmos | 7.4% |
| 303 | Optic Atrophy | 7.4% |
| 304 | Optic Neuritis | 7.4% |
| 305 | Papilledema | 7.4% |
| 306 | Pemphigoid, Benign Mucous Membrane | 7.4% |
| 307 | Strabismus | 7.4% |
| 308 | Tolosa-Hunt Syndrome | 7.4% |
| 309 | Orbital Cellulitis | 7.4% |
| 310 | Retrobulbar Hemorrhage | 7.4% |
| 311 | Corneal Endothelial Cell Loss | 7.4% |
| 312 | Adenoid Cystic Carcinoma | 7.4% |
| 313 | Adenocarcinoma, Clear Cell | 7.4% |
| 314 | Cholangiocarcinoma | 7.4% |
| 315 | Cervical Intraepithelial Neoplasia | 7.4% |
| 316 | Hyphema | 7.4% |
| 317 | Vitreous Hemorrhage | 7.4% |
| 318 | Nasopharyngeal carcinoma | 7.3% |
| 319 | Testicular Neoplasms | 7.1% |
| 320 | Leukoplakia | 7.1% |
| 321 | Lymphocele | 7.1% |
| 322 | Pancreatic Cyst | 7.1% |
| 323 | Adrenocortical carcinoma | 7% |
| 324 | granulosa cell tumor | 7% |
| 325 | Barrett Esophagus | 7% |
| 326 | Breast Cyst | 7% |
| 327 | Actinic keratosis | 7% |
| 328 | Mediastinal Cyst | 7% |
| 329 | Neoplasm Invasiveness | 7% |
| 330 | Neoplasm Metastasis | 7% |
| 331 | Neoplasm Recurrence, Local | 7% |
| 332 | Parovarian Cyst | 7% |
| 333 | Pericardial Cyst | 7% |
| 334 | Thymic Cyst | 7% |
| 335 | Carcinogenesis | 7% |
| 336 | Myxoid cyst | 7% |
| 337 | Metastasis | 7% |
| 338 | Retroperitoneal Neoplasms | 7% |
| 339 | Phyllodes Tumor | 7% |
| 340 | Hemangioendothelioma | 7% |
| 341 | Lipoma | 7% |
| 342 | Myoma | 7% |
| 343 | Myxoma | 7% |
| 344 | Angiolipoma | 7% |
| 345 | Myelolipoma | 7% |
| 346 | Neoplasms, Bone Tissue | 7% |
| 347 | Neoplasms, Fibrous Tissue | 7% |
| 348 | Smooth Muscle Tumor | 7% |
| 349 | Desmoplastic Small Round Cell Tumor | 7% |
| 350 | Chondroma | 7% |
| 351 | Enchondroma | 7% |
| 352 | Alveolar rhabdomyosarcoma | 6.9% |
| 353 | Waldenstrom Macroglobulinemia | 6.8% |
| 354 | Multiple Myeloma | 6.8% |
| 355 | Optic Neuropathy, Ischemic | 6.7% |
| 356 | Anterior Ischemic Optic Neuropathy | 6.7% |
| 357 | Anisocoria | 6.6% |
| 358 | Tonic Pupil | 6.6% |
| 359 | Eye pain | 6.6% |
| 360 | Orbital Myositis | 6.6% |
| 361 | Diplopia | 6.6% |
| 362 | Scotoma | 6.6% |
| 363 | Photophobia | 6.6% |
| 364 | Amaurosis | 6.6% |
| 365 | Blindness | 6.6% |
| 366 | Leukoplakia, Oral | 6.6% |
| 367 | Thyroid Nodule | 6.6% |
| 368 | Paraneoplastic Cerebellar Degeneration | 6.6% |
| 369 | Renal Cell Carcinoma | 6.5% |
| 370 | Papillary Renal Cell Carcinoma | 6.5% |
| 371 | Corpus Luteum Cyst | 6.3% |
| 372 | Ovarian Cysts | 6.3% |
| 373 | Mouth Neoplasms | 6.3% |
| 374 | Central Nervous System Neoplasms | 6.3% |
| 375 | Vascular Neoplasms | 6.3% |
| 376 | Thymus Neoplasms | 6.3% |
| 377 | Genital Neoplasms, Female | 6.2% |
| 378 | Breast Neoplasms, Male | 6.2% |
| 379 | Triple Negative Breast Neoplasms | 6.2% |
| 380 | Leukemia, Myelomonocytic, Chronic | 6.2% |
| 381 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 6.2% |
| 382 | Leydig Cell Tumor | 6.1% |
| 383 | Carcinoma, Endometrioid | 6.1% |
| 384 | Ophthalmoplegia | 6% |
| 385 | External Ophthalmoplegia | 6% |
| 386 | Limbic Encephalitis | 6% |
| 387 | Amblyopia | 6% |
| 388 | Klatskin Tumor | 5.9% |
| 389 | Denys-Drash Syndrome | 5.9% |
| 390 | Choledochal Cyst | 5.8% |
| 391 | Angle Closure Glaucoma | 5.8% |
| 392 | Glaucoma, Open-Angle | 5.8% |
| 393 | Panuveitis | 5.8% |
| 394 | Exfoliation Syndrome | 5.8% |
| 395 | Peutz-Jeghers Syndrome | 5.7% |
| 396 | Adrenal Gland Neoplasms | 5.7% |
| 397 | Gastrointestinal Neoplasms | 5.7% |
| 398 | Genital Neoplasms, Male | 5.7% |
| 399 | Liver neoplasms | 5.7% |
| 400 | Urologic Neoplasms | 5.6% |
| 401 | Mastocytosis | 5.6% |
| 402 | Sturge-Weber Syndrome | 5.6% |
| 403 | Lambert-Eaton Myasthenic Syndrome | 5.6% |
| 404 | Sebaceous Gland Neoplasms | 5.6% |
| 405 | Spinal Neoplasms | 5.6% |
| 406 | Bone Marrow Neoplasms | 5.6% |
| 407 | Gastrointestinal Stromal Tumors | 5.6% |
| 408 | Hemangioma, Cavernous | 5.6% |
| 409 | Leukemia, T-Cell | 5.6% |
| 410 | Leukemia, B-Cell | 5.6% |
| 411 | Ophthalmia Neonatorum | 5.5% |
| 412 | Lymphoma, Follicular | 5.5% |
| 413 | T-Cell Lymphoma | 5.5% |
| 414 | Mantle cell lymphoma | 5.5% |
| 415 | Alstrom Syndrome | 5.3% |
| 416 | Nose Neoplasms | 5.3% |
| 417 | Esotropia | 5.1% |
| 418 | Exotropia | 5.1% |
| 419 | Choroidal Neovascularization | 5.1% |
| 420 | Pituitary Adenoma | 5% |
| 421 | Pituitary Neoplasms | 5% |
| 422 | fibroma | 4.9% |
| 423 | Fibromatosis | 4.9% |
| 424 | Osteoblastoma | 4.9% |
| 425 | Osteoma | 4.9% |
| 426 | Rhabdomyoma | 4.9% |
| 427 | Chondromatosis | 4.9% |
| 428 | Hemangioblastoma | 4.9% |
| 429 | Lymphoma, Extranodal NK-T-Cell | 4.9% |
| 430 | Kearns-Sayre syndrome | 4.9% |
| 431 | Myelitis, Transverse | 4.8% |
| 432 | Palatal Neoplasms | 4.8% |
| 433 | ovarian neoplasm | 4.7% |
| 434 | Uveomeningoencephalitic Syndrome | 4.7% |
| 435 | Congenital nystagmus | 4.6% |
| 436 | Herpes Zoster Ophthalmicus | 4.6% |
| 437 | Hemianopsia | 4.6% |
| 438 | Amaurosis Fugax | 4.6% |
| 439 | Blindness, Cortical | 4.6% |
| 440 | Anterior uveitis | 4.5% |
| 441 | Uveitis, Posterior | 4.5% |
| 442 | Mastocytoma | 4.4% |
| 443 | Miller Fisher Syndrome | 4.4% |
| 444 | Mastocytosis, Systemic | 4.4% |
| 445 | Leukemia, Myeloid, Chronic-Phase | 4.3% |
| 446 | Graves Disease | 4.2% |
| 447 | Xeroderma Pigmentosum | 4.2% |
| 448 | Horner Syndrome | 4.2% |
| 449 | Pancreatic Pseudocyst | 4% |
| 450 | Lymphatic Metastasis | 4% |
| 451 | Meningeal Neoplasms | 4% |
| 452 | Neoplasms, Unknown Primary | 4% |
| 453 | Leukemic Infiltration | 4% |
| 454 | Neoplasm Micrometastasis | 4% |
| 455 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 3.9% |
| 456 | Leukemia, Large Granular Lymphocytic | 3.9% |
| 457 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3.9% |
| 458 | Lymphoma, T-Cell, Cutaneous | 3.9% |
| 459 | Lymphoma, AIDS-Related | 3.9% |
| 460 | Enteropathy-Associated T-Cell Lymphoma | 3.9% |
| 461 | Primary Effusion Lymphoma | 3.9% |
| 462 | Fibromatosis, Aggressive | 3.9% |
| 463 | Fibromatosis, Abdominal | 3.9% |
| 464 | Ear Neoplasms | 3.7% |
| 465 | Lung Neoplasms | 3.7% |
| 466 | Pleural Neoplasms | 3.7% |
| 467 | Brain Neoplasms | 3.6% |
| 468 | Salivary Gland Neoplasms | 3.6% |
| 469 | Spinal Cord Neoplasms | 3.6% |
| 470 | Tongue Neoplasms | 3.6% |
| 471 | Polycystic Ovary Syndrome | 3.6% |
| 472 | Uterine Neoplasms | 3.6% |
| 473 | Vaginal Neoplasms | 3.6% |
| 474 | Vulvar Neoplasms | 3.6% |
| 475 | Uterine Cancer | 3.6% |
| 476 | Fallopian Tube Neoplasms | 3.6% |
| 477 | Sicca Syndrome | 3.5% |
| 478 | Sjogren's Syndrome | 3.5% |
| 479 | Pharyngeal Neoplasms | 3.4% |
| 480 | Central Nervous System Cysts | 3.3% |
| 481 | Ophthalmoplegic Migraine | 3.3% |
| 482 | Bile Duct Neoplasms | 3.3% |
| 483 | gallbladder neoplasm | 3.3% |
| 484 | Intestinal Neoplasms | 3.3% |
| 485 | Penile Neoplasms | 3.3% |
| 486 | Prostatic Neoplasms | 3.3% |
| 487 | Stomach Neoplasms | 3.3% |
| 488 | Progressive supranuclear palsy | 3.3% |
| 489 | Polycythemia Vera | 3.3% |
| 490 | Burkitt Lymphoma | 3.3% |
| 491 | Dupuytren Contracture | 3.1% |
| 492 | Urticaria Pigmentosa | 3.1% |
| 493 | Laryngeal neoplasm | 3.1% |
| 494 | Mycosis Fungoides | 3.1% |
| 495 | Lymphomatoid Papulosis | 3.1% |
| 496 | Plasmablastic lymphoma | 3.1% |
| 497 | Neuromyelitis Optica | 3.1% |
| 498 | Bladder Neoplasm | 3% |
| 499 | Kidney Neoplasm | 3% |
| 500 | Ureteral Neoplasms | 3% |
| 501 | Urethral Neoplasms | 3% |
| 502 | Meningeal Carcinomatosis | 2.9% |
| 503 | Bronchial Neoplasms | 2.6% |
| 504 | Multiple Pulmonary Nodules | 2.6% |
| 505 | Supratentorial Neoplasms | 2.6% |
| 506 | Endometrial Neoplasms | 2.6% |
| 507 | Zollinger-Ellison syndrome | 2.6% |
| 508 | Sezary Syndrome | 2.6% |
| 509 | Behcet Syndrome | 2.4% |
| 510 | Hypopharyngeal Neoplasms | 2.4% |
| 511 | Pleural Effusion, Malignant | 2.4% |
| 512 | Hypopharyngeal Cancer | 2.4% |
| 513 | Parotid Neoplasms | 2.4% |
| 514 | Prostatic Neoplasms, Castration-Resistant | 2.4% |
| 515 | Nelson Syndrome | 2.4% |
| 516 | Cell Transformation, Viral | 2.3% |
| 517 | Cecal Neoplasms | 2.2% |
| 518 | Duodenal Neoplasms | 2.2% |
| 519 | Brain Stem Neoplasms | 2.1% |
| 520 | Nasopharyngeal Neoplasms | 2% |
| 521 | Colorectal Neoplasms | 2% |
| 522 | Tonsillar Neoplasms | 1.9% |
| 523 | Cerebellar Neoplasms | 1.9% |
| 524 | Paranasal Sinus Neoplasms | 1.9% |
| 525 | Choroid Plexus Papilloma | 1.9% |
| 526 | Appendiceal Neoplasms | 1.8% |
| 527 | Colonic Neoplasms | 1.8% |
| 528 | Rectal Neoplasms | 1.8% |
| 529 | Maxillary Sinus Neoplasms | 1.5% |
| 530 | Anus Neoplasms | 1.4% |
| 531 | Sigmoid Neoplasms | 1.4% |
| 532 | Radicular Cyst | 1.1% |